Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Prizma Pulse Oximeter Evaluation

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Веза се чува у привремену меморију
СтатусЗавршено
Спонзори
G Medical Innovations Ltd.

Кључне речи

Апстрактан

This study is intended to evaluate performance of the new design sufficiently to support performance claims for an FDA 510K submission or ISO technical file. Specifically:
- SpO2 value range 70% to 100%
- 10 or more subjects, at least 3 of dark pigmentation
- At least 200 data points
- Meeting the following test required by the 2013 FDA Guidance on Pulse Oximeters - Premarket Notification Submissions and by ISO 80601-2-61 on Pulse Oximeters:
- 2013 FDA Guidance on Pulse Oximeters - Premarket Notification Submissions:
- 4.1. ACCURACY OF PULSE OXIMETERS
- 4.1.1 IN VIVO TESTING FOR SPO2 ACCURACY UNDER LABORATORY CONDITIONS
- ISO 80601-2-61:2011 Annex EE.2 and clause 201.12.1.101.2
- 201.12.1.101 SpO2 accuracy of pulse oximeter equipment
- 201.12.1.101.2 Determination of SpO2 accuracy

Опис

The device under test was the Prizma which is a phone cover biometric device that includes reflectance oximetry. This device is a spot checker that requires the patient to hold their finger on the sensor during the measurement. The subjects were asked not to move during the study. In order to get consistent measurements the fingers were taped to the test device. The tape acted mainly as a reminder, and there were some problems with finger movement. A radial arterial cannula was placed in either the left or right wrist of each subject.

Blood gas analysis to determine oxyhemoglobin saturation was performed on an OSM-3® multi-wavelength oximeter (Hemoximeter, Radiometer, Copenhagen). No subject was anemic (Hemoglobin ≤ 10gm•dl-1). Each subject had control data taken at the beginning of each experiment, with two control blood samples drawn while breathing room air. Hypoxia was induced to different levels of oxyhemoglobin saturation (between 70-100%) by having subjects breathe mixtures of nitrogen, room air, and carbon dioxide. Oxyhemoglobin saturation was reduced to a series of targets and stabilized at the plateau value. Each plateau level of oxyhemoglobin saturation was maintained for at least 30 seconds. Two arterial blood samples were then obtained, approximately 30 seconds apart. A total of 24 samples were obtained per subject. Data were recorded by Bickler-Ye lab and provided for analysis.

Датуми

Последња верификација: 02/28/2017
Фирст Субмиттед: 02/26/2017
Предвиђена пријава послата: 03/08/2017
Прво објављено: 03/14/2017
Послато последње ажурирање: 03/08/2017
Последње ажурирање објављено: 03/14/2017
Стварни датум почетка студије: 04/14/2016
Процењени датум примарног завршетка: 04/14/2016
Предвиђени датум завршетка студије: 04/15/2016

Стање или болест

Oxygen Deficiency

Интервенција / лечење

Device: Prizma

Фаза

-

Групе руку

АрмИнтервенција / лечење
Prizma
Measurement of oxyhemoglobin saturation by OSM-3 oximeter and Prizma oxygen saturation measurement
Device: Prizma
A radial arterial cannula was placed in either the left or right wrist of each subject. Blood gas analysis to determine oxyhemoglobin saturation was performed on an OSM-3® multi-wavelength oximeter (Hemoximeter, Radiometer, Copenhagen). No subject was anemic (Hemoglobin ≤ 10gm•dl-1).

Критеријуми

Узраст подобан за студирање 21 Years До 21 Years
Полови подобни за студирањеAll
Метода узорковањаNon-Probability Sample
Прихвата здраве волонтереда
Критеријуми

Inclusion Criteria:

- Both male and female subjects

- Healthy subjects capable of undergoing controlled hypoxemia to the levels outlined in the desaturation profile below.

- Meeting the demographic requirements listed above.

Exclusion Criteria:

- Smokers or individuals exposed to high levels of carbon monoxide that result in carboxyhemoglobin levels over 3% as tested by the BYL.

- Subjects who would be placed under medical risk under the desaturation profile listed below.

- Significant arrhythmia

- Age below 21 or over 50

- Pregnant women

Исход

Примарне мере исхода

1. Blood oxygen saturation [2 days]

Comparison of Measurements: Prizma Device versus Gold Standard

Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge